Astellas, Evopoint Ink Exclusive Deal for CLDN18.2-Targeting ADC XNW27011
Astellas Secures Global Rights to Evopoint’s Promising CLDN18.2-Targeting Antibody-Drug Conjugate XNW27011 in Strategic Oncology Expansion In a strategic move that reinforces its commitment to precision oncology, Astellas Pharma Inc. has…
Analysts Downplay Intellia Setback, Gene Therapy Safety Still in Focus
Intellia Grapples with Safety Questions in ATTR Gene Editing Trial Amid Broader Sector Scrutiny Intellia Therapeutics’ stock took a steep dive Thursday morning, shedding approximately 26% of its value after…
CVS Health Sues to Shield Arkansans from Impact of Act 624
CVS Health Files Federal Lawsuit to Halt Arkansas’ Act 624, Citing Harm to Patients, Jobs, and Healthcare Access On May 29, 2025, CVS Health® filed a federal lawsuit seeking to…
Beyfortus Gains Edge in First Real-World RSV Immunization Comparison
Beyfortus Shows Stronger Public Health Impact Than Maternal RSV Vaccine in Landmark Real-World Comparison In a pivotal step forward for infant respiratory health, new real-world data from an immunization program…
Member States Back World Prematurity Day as Global Health Campaign
Member States Officially Endorse World Prematurity Day as a Global Health Campaign at the 78th World Health Assembly At the recently concluded 78th World Health Assembly (WHA), a historic and…
WHO Unveils New Framework Linking Climate Change and Tuberculosis Control
WHO Launches Comprehensive Framework Addressing the Intersection of Climate Change and Tuberculosis In a decisive move to confront two of the world’s most pressing public health challenges, the World Health…
78th World Health Assembly Concludes with Historic Milestones
Global Unity, Historic Milestones: 78th World Health Assembly Concludes with Ambitious Health Agenda The Seventy-eighth World Health Assembly (WHA78), the flagship decision-making forum of the World Health Organization (WHO), drew…
Elanco Appoints Bob VanHimbergen to CFO Role
Elanco Names Robert VanHimbergen as New CFO, Succeeding Todd Young in Strategic Leadership Transition Elanco Animal Health Incorporated has officially announced the appointment of Robert (Bob) VanHimbergen as Executive Vice…
EU Approves Subcutaneous Opdivo with Halozyme’s ENHANZE for Multiple Tumors
Halozyme and Bristol Myers Squibb Secure European Commission Approval for Subcutaneous Opdivo Co-Formulated with ENHANZE in Multiple Solid Tumors Halozyme Therapeutics celebrates a significant regulatory milestone as Bristol Myers Squibb…
BeOne Medicines Launches in Switzerland, Begins New Global Oncology Chapter
BeOne Medicines Officially Launches Following Redomiciliation to Switzerland, Ushering in a New Era of Global Oncology Leadership BeOne Medicines Ltd. formerly known as BeiGene, Ltd., has officially entered a transformative…
BioNTech to Showcase Oncology Pipeline Progress at ASCO 2025
BioNTech to Showcase Broad Advancements in Oncology Pipeline at 2025 ASCO Annual Meeting BioNTech ,a global biotechnology company known for pioneering mRNA-based technologies, announced that it will present significant clinical…
Pharma Boosts R&D Spending Despite 2024 Headwinds
Pharma Doubles Down on R&D Amid Global Headwinds, Eyes Nearly $340 Billion in Investment by 2030 Despite formidable political and economic challenges ranging from inflation and rising operational costs to…